| HM05203 | GATAD2B | larynx | MESH:D056487 | Drug-Induced Liver Injury, Chronic | liver |
| HM05203 | GATAD2B | larynx | MESH:D006505 | Hepatitis | |
| HM05203 | GATAD2B | larynx | MESH:D003294 | Seizures, Febrile | |
| HM05203 | GATAD2B | larynx | MESH:D000014 | Abnormalities, Drug-Induced | |
| HM05203 | GATAD2B | larynx | MESH:D020191 | Myoclonic Epilepsies, Progressive | nerve |
| HM05203 | GATAD2B | larynx | MESH:D020191 | Myoclonic Epilepsies, Progressive | muscle |
| HM05203 | GATAD2B | larynx | MESH:D006528 | Carcinoma, Hepatocellular | liver |
| HM05203 | GATAD2B | larynx | MESH:D002386 | Cataract | pancreas |
| HM05203 | GATAD2B | larynx | MESH:D002386 | Cataract | eye |
| HM05203 | GATAD2B | larynx | MESH:D017114 | Liver Failure, Acute | |
| HM05203 | GATAD2B | larynx | MESH:D056486 | Drug-Induced Liver Injury | |
| HM05203 | GATAD2B | larynx | MESH:D012640 | Seizures | muscle |
| HM05203 | GATAD2B | larynx | MESH:D005234 | Fatty Liver | |
| HM05203 | GATAD2B | larynx | MESH:D008106 | Liver Cirrhosis, Experimental | |
| HM05203 | GATAD2B | larynx | MESH:D006932 | Hyperbilirubinemia | |
| HM05203 | GATAD2B | larynx | MESH:D010018 | Osteomalacia | bone |
| HM05203 | GATAD2B | larynx | MESH:D008546 | Melanoma, Experimental | |
| HM05203 | GATAD2B | larynx | MESH:D002493 | Central Nervous System Diseases | spinal cord |
| HM05203 | GATAD2B | larynx | MESH:D002493 | Central Nervous System Diseases | skin |
| HM05203 | GATAD2B | larynx | MESH:D002493 | Central Nervous System Diseases | nerve |
| HM05203 | GATAD2B | larynx | MESH:D002493 | Central Nervous System Diseases | muscle |
| HM05203 | GATAD2B | larynx | MESH:D002493 | Central Nervous System Diseases | eye |
| HM05203 | GATAD2B | larynx | MESH:D002493 | Central Nervous System Diseases | brain |
| HM05203 | GATAD2B | larynx | MESH:D006529 | Hepatomegaly | |
| HM05203 | GATAD2B | larynx | MESH:D004830 | Epilepsy, Tonic-Clonic | muscle |
| HM05203 | GATAD2B | larynx | MESH:D019310 | Pseudolymphoma | |
| HM05203 | GATAD2B | larynx | MESH:D004832 | Epilepsy, Absence | muscle |
| HM05203 | GATAD2B | larynx | MESH:D001321 | Autistic Disorder | |
| HM05203 | GATAD2B | larynx | MESH:D010190 | Pancreatic Neoplasms | pancreas |
| HM05203 | GATAD2B | larynx | MESH:D017029 | Epilepsy, Complex Partial | muscle |
| HM05203 | GATAD2B | larynx | MESH:D005355 | Fibrosis | |
| HM05203 | GATAD2B | larynx | MESH:D006930 | Hyperalgesia | |
| HM05203 | GATAD2B | larynx | MESH:D008113 | Liver Neoplasms | |
| HM05203 | GATAD2B | larynx | MESH:D008113 | Liver Neoplasms | |
| HM05203 | GATAD2B | larynx | MESH:D002252 | Carbon Tetrachloride Poisoning | |
| HM05203 | GATAD2B | larynx | MESH:D004828 | Epilepsies, Partial | muscle |
| HM05203 | GATAD2B | larynx | MESH:D008107 | Liver Diseases | skin |
| HM05203 | GATAD2B | larynx | MESH:D008107 | Liver Diseases | muscle |
| HM05203 | GATAD2B | larynx | MESH:D008107 | Liver Diseases | lung |
| HM05203 | GATAD2B | larynx | MESH:D008107 | Liver Diseases | liver |
| HM05203 | GATAD2B | larynx | MESH:D010146 | Pain | |
| HM05203 | GATAD2B | larynx | MESH:D000799 | Angioedema | skin |
| HM05203 | GATAD2B | larynx | MESH:D007674 | Kidney Diseases | ureter |
| HM05203 | GATAD2B | larynx | MESH:D007674 | Kidney Diseases | pituitary |
| HM05203 | GATAD2B | larynx | MESH:D007674 | Kidney Diseases | kidney |
| HM05203 | GATAD2B | larynx | MESH:D008103 | Liver Cirrhosis | liver |
| HM05203 | GATAD2B | larynx | MESH:D008114 | Liver Neoplasms, Experimental | |
| HM05203 | GATAD2B | larynx | MESH:D004421 | Dystonia | |
| HM05203 | GATAD2B | larynx | MESH:D004827 | Epilepsy | muscle |
| HM05203 | GATAD2B | larynx | MESH:D014581 | Urticaria | skin |
| HM05203 | GATAD2B | larynx | MESH:D017093 | Liver Failure | |
| HM05203 | GATAD2B | larynx | MESH:D004831 | Epilepsies, Myoclonic | muscle |
| HM05203 | GATAD2B | larynx | MESH:D019636 | Neurodegenerative Diseases | nerve |
| HM05203 | GATAD2B | larynx | MESH:D011230 | Precancerous Conditions | |
Homer